TABLE 7.
AUTHOR (n=8) | GENDER | AGE (YEARS) | MGUS | BCVA, RIGHT, LEFT | FOLLOW-UP (YEARS) | TREATMENT |
---|---|---|---|---|---|---|
Yassa52 | M | 34 | +, IgG heavy and light chain | R: 6/6 L: 6/15 |
20 | Bilateral penetrating keratoplasty |
Spiegel53 | M | 76 | +, IgGκ light chain | R: 6/60 L: 20/400 |
3 | Bilateral penetrating keratoplasty |
Stirling54 | F | 73 | +, IgGκ and IgMκ | Not reported | Not reported | Bilateral penetrating keratoplasty |
Stirling54 | M | 42 | +, IgGκ light | Not reported | Not reported | Bilateral penetrating keratoplasty |
Kamal55 | M | 65 | +, M spike | R: 6/7.5 L: 6/10 |
Not reported | Not reported |
Lisch21 | F | 49 | +, IgGκ light chain | R: 6/20 L: 6/12 |
Transformation from lattice-like to fleck-like PPK during 20 years | Not reported |
Hall22 | M | 66 | +, IgGκ | R: 6/6 L: 6/6 |
Several months | Not reported |
BCVA, best-corrected visual acuity; Ig, G immunoglobulin G; L, left; M spike, monoclonal spike; PPK, paraproteinemic keratopathy; R, right.